Bronchiectasis Market Size, Industry Trends, Opportunity, Overview and Forecast 2023-2033

Bronchiectasis Market Report Overview:

Report Attribute Details
Base Year 2022
Forecast Years 2023-2033
Historical Years 2017-2022
Market Growth (2023-2033) 4.96%

The report offers a comprehensive analysis of the bronchiectasis market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market's performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the bronchiectasis market.

Request a Free PDF Sample for More Detailed Market Insights:
https://www.imarcgroup.com/bronchiectasis-market/requestsample

The bronchiectasis market is expected to exhibit a CAGR of 4.96% during 2023-2033. Bronchiectasis is a lasting respiratory disease characterized by irreversible enlargement and damage to the lung's airways. In this condition, the bronchi, which are the primary lung airways, become less elastic, wider, and thicker, which results in mucus accumulation and hinders the effective removal of irritants and bacteria from the airways. Common symptoms include continuous cough-producing thick mucus, regular respiratory infections, wheezing, shortness of breath, fatigue, chest discomfort, and others. Diagnostic methods involve reviewing medical histories, performing physical evaluations, using imaging scans, and undertaking lung function assessments. High-resolution computed tomography (HRCT) provides detailed images of the airways, aiding in identifying bronchiectasis and its severity. Lung function tests, such as spirometry, gauge lung efficacy, and associated issues.

Driving the bronchiectasis market are the rising instances of severe respiratory diseases like pneumonia, tuberculosis, and pertussis, which cause inflammation and airway wall damage. The market's positive trajectory is also supported by the increasing cases of autoimmune disorders, including cystic fibrosis, rheumatoid arthritis, and immunodeficiency disorders that heighten the bronchiectasis risk. The common usage of mucolytic drugs like hypertonic saline and mannitol, which help in liquefying mucus for more efficient clearance, is further boosting the market growth. Additionally, major industry investments in research and innovation, especially focusing on biologics such as monoclonal antibodies to minimize airway inflammation and thwart exacerbations, fuel market expansion. The growing demand for oscillatory positive expiratory pressure devices (OPEP), portable devices producing airway vibrations during exhaling to improve mucus clearance, is anticipated to significantly influence the bronchiectasis market in the upcoming years.

Countries Covered:

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Analysis Covered Across Each Country:

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the bronchiectasis market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the bronchiectasis market
Reimbursement scenario in the market
In-market and pipeline drugs

This report also provides a detailed analysis of the current bronchiectasis marketed drugs and late-stage pipeline drugs.

In-Market Drugs:

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs:

Drug overview
Mechanism of action
Regulatory status
Clinical trial results
Drug uptake and market performance

Competitive Landscape With Key Players:

The competitive landscape of the bronchiectasis market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of the Key Players :

Renovion
Boehringer Ingelheim
SolAeroMed
AstraZeneca

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=8476&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Other Related Reports: 

Acoustic Neuroma Market Size

Partial Epilepsy Market Size

Lamellar Ichthyosis Market Size

Contact Us:

IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.